查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477183

藥品折扣卡市場按類型、治療類別、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Drug Discount Card Market By Type, By Therapeutic Category, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年藥品折扣卡市場規模為 1716.21 億美元，2024 年至 2032 年複合年成長率為 8.5%。

藥品折扣卡市場-市場動態

處方藥成本上漲推動藥品折扣卡市場激增

消費者擴大使用這些卡片來減輕與購買藥物相關的經濟負擔，盡可能尋求折扣和節省。根據國家醫學圖書館的數據，2022年，美國處方藥總體支出增加了4.0%至6.0%。隨著處方藥成本持續攀升，對負擔得起的替代品的需求推動了藥品折扣卡市場的激增。處方藥價格不斷上漲已成為市場擴張的重要推動力，凸顯了對可用解決方案的迫切需求，以減輕醫療費用上漲對個人和家庭的影響。

藥品折扣卡市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.5% 左右的複合年成長率成長

根據類型細分，預計通用卡將在 2023 年顯示最大的市場佔有率

依治療類別細分，2023年抗癌藥物為主導類型

從配銷通路細分來看，2023年線上為主導類型

按地區分類，北美是 2023 年的主要收入來源

藥品折扣卡市場-細分分析：

全球藥品折扣卡市場根據類型、治療類別、配銷通路和地區進行細分。

市場依類型分為兩類：在類型類別下，市場分為品牌卡和通用卡，代表提供處方藥折扣的不同方法。品牌卡通常為品牌藥物提供折扣，而通用卡則專注於為通用藥物提供折扣。

根據治療類別，市場分為四個類別： 在治療類別細分方面，市場根據折扣卡涵蓋的藥物類型進行細分。這包括對於控制血糖水平至關重要的糖尿病藥物；止痛藥有助於緩解不適和控制慢性疼痛，對於治療各種類型的癌症至關重要。

藥品折扣卡市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

在北美，尤其是美國，市場高度發達，並受到處方藥成本上漲的推動，導致折扣卡計劃被廣泛採用。由於醫療保健成本增加以及改善獲得負擔得起的藥物的機會的推動，歐洲對藥品折扣卡的需求也不斷成長。在印度和中國等新興經濟體，由於醫療保健意識不斷提高以及對具有成本效益的醫療保健解決方案的需求，市場正在迅速擴大。

藥品折扣卡市場-競爭格局：

藥品折扣卡市場競爭格局的特徵是多元化的參與者爭奪市場佔有率。主要利害關係人包括製藥公司、連鎖藥局、醫療保健技術公司和專業折扣卡提供者。大型製藥公司經常提供品牌藥品折扣卡，作為患者援助計劃的一部分，以提高藥物取得和品牌忠誠度。藥房連鎖店利用其廣泛的網路來分發折扣卡並吸引顧客。

最近的發展：

2023 年 9 月，Elevance 推出了 CarelonRx，這是一項新計劃，旨在讓會員更輕鬆地在藥房櫃檯獲得藥品折扣。 CarelonRx 提供藥物補充、更新、定價以及送貨上門的數位工具。

目錄

第 1 章：藥品折扣卡市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的藥品折扣卡市場片段
    • 按治療類別分類的藥物折扣卡市場片段
    • 按配銷通路分類的藥品折扣卡市場片段
    • 按國家/地區分類的藥品折扣卡市場片段
    • 按地區分類的藥品折扣卡市場片段
  • 競爭洞察

第 3 章：藥品折扣卡主要市場趨勢

  • 藥品折扣卡市場促進因素
    • 市場促進因素的影響分析
  • 藥品折扣卡市場限制
    • 市場限制影響分析
  • 藥品折扣卡市場機會
  • 藥品折扣卡市場未來趨勢

第 4 章：藥品折扣卡產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：藥品折扣卡市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：藥品折扣卡市場格局

  • 2023 年藥品折扣卡市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：藥品折扣卡市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 品牌卡
    • 通用卡

第 8 章：藥品折扣卡市場 - 按治療類別

  • 概述
    • 按治療類別分類的細分市場佔有率分析
    • 糖尿病藥物
    • 止痛藥
    • 心理健康藥物
    • 癌症藥物
    • 其他

第 9 章：藥品折扣卡市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 離線
    • 線上

第 10 章：藥品折扣卡市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 藥品折扣卡北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按治療類別）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 藥品折扣卡歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按治療類別）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 藥品折扣卡亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模和預測（按治療類別）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 藥品折扣卡拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模和預測（按治療類別）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 藥品折扣卡中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按治療類別）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 藥品折扣卡產業

  • 競爭儀表板
  • 公司簡介
    • GoodRx
    • SingleCare
    • WellCard Savings
    • RxSaver
    • Optum Perks
    • Kroger Prescription Savings Club
    • ScriptSave
    • Walmart Rx Savings Program
    • Prescription Hope
    • FamilyWize
    • NeedyMeds
    • Humana
    • AARP Prescription Discounts (UnitedHealth Group)
    • Blink Health
    • Coast2Coast Rx
    • HealthWarehouse.com, Inc.
    • Inside Rx (Express Scripts)
    • Simple Savings Card
    • United Networks of America
    • USA Rx
    • Watertree Health
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2581

REPORT HIGHLIGHT

Drug Discount Card Market size was valued at USD 1,716.21 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

The Drug Discount Card Market provides consumers with discounted prices on prescription medications through various platforms or programs. The rapid expansion of digital platforms and mobile applications offers convenient access to discounts and medication information. However, the market faces restraints such as regulatory complexities, varying discount regulations across regions, and concerns regarding data privacy and security. The increasing demand for affordable medications, especially among underserved populations, and the potential for partnerships with healthcare stakeholders to enhance patient outcomes is an opportunity for the market.

Drug Discount Card Market- Market Dynamics

Rising prescription drug costs fuel the surge in the drug discount card market

Consumers are increasingly turning to these cards to alleviate the financial burden associated with purchasing medications, seeking discounts and savings wherever possible. According to the National Library of Medicine, in 2022, the overall prescription drug spending has risen by 4.0% to 6.0% in the United States. As prescription drug costs continue to climb, the demand for affordable alternatives has propelled a surge in the Drug Discount Card Market. The escalating prices of prescription drugs have become a significant driver in the market's expansion, highlighting the critical need for accessible solutions to mitigate the impact of rising healthcare expenses on individuals and families.

Drug Discount Card Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, Generic card was predicted to show maximum market share in the year 2023

Based on Therapeutic Category segmentation, Cancer drugs were the leading type in 2023

Based on Distribution Channel segmentation, online was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Drug Discount Card Market- Segmentation Analysis:

The Global Drug Discount Card Market is segmented based on Type, Therapeutic Category, Distribution Channel, and Region.

The market is divided into two categories based on Type: Under the type category, the market is divided into Branded Cards and Generic Cards, representing distinct approaches to providing discounts on prescription medications. Branded Cards typically offer discounts on brand-name drugs, while Generic Cards focus on providing savings for generic medications.

The market is divided into four categories based on Therapeutic Category: In terms of therapeutic category segmentation, the market is segmented based on the types of medications covered by the discount cards. This includes Diabetes drugs, which are crucial for managing blood sugar levels; Pain medications, which help alleviate discomfort and manage chronic pain conditions and are essential for treating various types of cancer.

Drug Discount Card Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

In North America, particularly in the United States, the market is highly developed and driven by the rising cost of prescription drugs, leading to the widespread adoption of discount card programs. Europe also exhibits a growing demand for drug discount cards, fueled by increasing healthcare costs and efforts to improve access to affordable medications. In emerging economies such as India and China, the market is expanding rapidly due to rising healthcare awareness and the need for cost-effective healthcare solutions.

Drug Discount Card Market- Competitive Landscape:

The competitive landscape of the Drug Discount Card Market is characterized by a diverse range of players vying for market share. Key stakeholders include pharmaceutical companies, pharmacy chains, healthcare technology firms, and specialized discount card providers. Major pharmaceutical companies often offer branded drug discount cards as part of patient assistance programs to enhance medication access and brand loyalty. Pharmacy chains leverage their extensive networks to distribute discount cards and attract customers.

Recent Developments:

In September 2023, Elevance launched CarelonRx, a new program that aims to make it easier for members to access drug discounts at the pharmacy counter. CarelonRx offers digital tools for medication refilling, renewal, and pricing, as well as home delivery.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG DISCOUNT CARD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GoodRx

SingleCare

WellCard Savings

RxSaver

Optum Perks

Kroger Prescription Savings Club

ScriptSave

Walmart Rx Savings Program

Prescription Hope

FamilyWize

NeedyMeds

Humana

AARP Prescription Discounts (UnitedHealth Group)

Blink Health

Coast2Coast Rx

HealthWarehouse.com, Inc.

Inside Rx (Express Scripts)

Simple Savings Card

United Networks of America

USA Rx

Watertree Health

Others

GLOBAL DRUG DISCOUNT CARD MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Branded Cards
  • Generic Cards

GLOBAL DRUG DISCOUNT CARD MARKET, BY THERAPEUTIC CATEGORY- MARKET ANALYSIS, 2019 - 2032

  • Diabetes drugs
  • Pain medications
  • Mental health medications
  • Cancer drugs
  • Others

GLOBAL DRUG DISCOUNT CARD MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Offline
  • Online

GLOBAL DRUG DISCOUNT CARD MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Drug Discount Card Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Drug Discount Card Market Snippet by Type
    • 2.1.2.Drug Discount Card Market Snippet by Therapeutic Category
    • 2.1.3.Drug Discount Card Market Snippet by Distribution Channel
    • 2.1.4.Drug Discount Card Market Snippet by Country
    • 2.1.5.Drug Discount Card Market Snippet by Region
  • 2.2.Competitive Insights

3.Drug Discount Card Key Market Trends

  • 3.1.Drug Discount Card Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Drug Discount Card Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Drug Discount Card Market Opportunities
  • 3.4.Drug Discount Card Market Future Trends

4.Drug Discount Card Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Drug Discount Card Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Drug Discount Card Market Landscape

  • 6.1.Drug Discount Card Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Drug Discount Card Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Branded Cards
    • 7.1.3.Generic Cards

8.Drug Discount Card Market - By Therapeutic Category

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Therapeutic Category, 2023 & 2032 (%)
    • 8.1.2.Diabetes drugs
    • 8.1.3.Pain medications
    • 8.1.4.Mental health medications
    • 8.1.5.Cancer drugs
    • 8.1.6.Others

9.Drug Discount Card Market - By Distribution Channel

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2.Offline
    • 9.1.3.Online

10.Drug Discount Card Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Drug Discount Card Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Drug Discount Card Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Drug Discount Card Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Drug Discount Card Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Drug Discount Card Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Drug Discount Card Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.GoodRx
    • 11.2.2.SingleCare
    • 11.2.3.WellCard Savings
    • 11.2.4.RxSaver
    • 11.2.5.Optum Perks
    • 11.2.6.Kroger Prescription Savings Club
    • 11.2.7.ScriptSave
    • 11.2.8.Walmart Rx Savings Program
    • 11.2.9.Prescription Hope
    • 11.2.10.FamilyWize
    • 11.2.11.NeedyMeds
    • 11.2.12.Humana
    • 11.2.13.AARP Prescription Discounts (UnitedHealth Group)
    • 11.2.14.Blink Health
    • 11.2.15.Coast2Coast Rx
    • 11.2.16.HealthWarehouse.com, Inc.
    • 11.2.17.Inside Rx (Express Scripts)
    • 11.2.18.Simple Savings Card
    • 11.2.19.United Networks of America
    • 11.2.20.USA Rx
    • 11.2.21.Watertree Health
    • 11.2.22.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Drug Discount Card Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Drug Discount Card Market, by Type 2019-2032 (USD Million)
  • TABLE Drug Discount Card Market: Therapeutic Category Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Category
  • TABLE Global Drug Discount Card Market, by Therapeutic Category 2019-2032 (USD Million)
  • TABLE Drug Discount Card Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Drug Discount Card Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Drug Discount Card Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Drug Discount Card Market, by Region 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)